Post-finasteride syndrome: our current knowledge
5-α reductase inhibitors are effective and commonly used medications for the treatment of benign prostatic hyperplasia. However, there are some questions about the safety of such medications. A post-finasteride syndrome is a controversial syndrome associated with a constellation of sexual, physical,...
Main Authors: | A. A. Galushkin, D. G. Likhikh, M. I. Kogan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation
2020-07-01
|
Series: | Vestnik Urologii |
Subjects: | |
Online Access: | https://www.urovest.ru/jour/article/view/330 |
Similar Items
-
Post-finasteride syndrome,
by: Ana Francisca Junqueira Ribeiro Pereira, et al.
Published: (2020-07-01) -
Post-finasteride syndrome: An emerging clinical problem
by: Silvia Diviccaro, et al.
Published: (2020-05-01) -
Finasteride for hair loss: a review
by: A. K. Gupta, et al.
Published: (2022-05-01) -
Finasteride as a model for personalized medicine
by: Ion G. Motofei, et al.
Published: (2017-10-01) -
The postfinasteride syndrome; an overview
by: David L. Rowland, et al.
Published: (2016-10-01)